Idaho will receive $36,141 from the latest settlement of illegal drug marketing allegations by the drug company Pfizer.
The U.S. Justice Department announced Tuesday that Pfizer Inc. will pay about $491 million to settle claims that Wyeth a company Pfizer bought in October 2009 had trained doctors and paid them bonuses to prescribe the kidney-transplant drug Rapamune for unapproved uses. About $257 million of the agreement is for civil settlements with state and federal governments. The rest was criminal fines and asset forfeitures.
The Medicaid Fraud Control Unit of the Idaho Attorney General's Office participated in the case. The total amount of Idaho's share is about $135,420, but most of that will go toward federal Medicaid payments. The rest, about $36,141, will be split evenly between Idaho's Medicaid program and the state general fund, which is the allocation for a Medicaid fraud settlement under Idaho law.
Audrey Dutton: 377-6448, @IDS_Audrey